Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate
- 17 September 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 344 (8925) , 791-792
- https://doi.org/10.1016/s0140-6736(94)92345-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infectionThe Lancet, 1994
- Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune statusThe Lancet, 1993
- Purity of factor VIII concentrates and serial CD4 countsThe Lancet, 1993
- The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate [see comments]Blood, 1991
- A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaNew England Journal of Medicine, 1989
- Trend and homogeneity analyses of proportions and life table dataComputers and Biomedical Research, 1977